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Macromolecular complexes: SMN — the master assembler
Michael P. Terns and Rebecca M. Terns
Recent studies indicate that the protein affected in
spinal muscular atrophy, SMN, plays a role in the
assembly of a number of macromolecular complexes
that function in the nucleus, interacting with its partner
proteins via their arginine- and glycine-rich domains. 
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Loss of the ‘survival of motor neurons’ protein, SMN, is
responsible for spinal muscular atrophy, one of the leading
hereditary causes of infant mortality [1]. The disease is
characterized by degeneration of motor neurons in the spinal
cord, resulting in muscle weakness and frequently in death
during childhood. Identification of the cellular functions of
SMN may provide a basis for understanding why reduced
levels of SMN result in the clinical symptoms of spinal
muscular atrophy, and may suggest therapeutic strategies
for treatment of spinal muscular atrophy patients. 
Recent studies [2–8] have revealed connections between
SMN and a variety of cellular proteins: the Sm and Sm-
like (LSm) proteins which associate with small nuclear
(sn)RNAs; fibrillarin and GAR1, which associate with small
nucleolar (sno)RNAs; RNA helicase A, which interacts
with RNA polymerase II; and the coilin protein of intranu-
clear ‘Cajal bodies’. SMN interacts with these proteins by
a common mechanism involving arginine and glycine
(RG)-rich domains in the partner proteins. It has been well
demonstrated that SMN plays a role in the assembly of
complexes of Sm proteins and small nuclear RNAs [9–14].
The new studies suggest that SMN may function as a
master assembler for complexes involved in ribosome
production, transcription and pre-mRNA splicing. The
studies also point to Cajal bodies as sites where the nuclear
SMN-mediated assembly reactions take place.
Splicing: assembly of snRNPs and spliceosomes
Pre-mRNA splicing requires the action of snRNPs,
RNA–protein complexes containing the snRNAs U1, U2,
U4, U5 and U6. The U1, U2, U4, and U5 snRNAs assemble
into complexes with the Sm proteins B/B′, D1–3 and E–G;
U6 snRNA associates with LSm proteins. Ultimately, the
individual mature snRNP complexes organize into spliceo-
somes: dynamic, higher-order ribonucleoprotein com-
plexes which catalyze the pre-mRNA splicing reactions.
The first insight into the role of SMN in assembly of
complexes came from experiments by the Dreyfuss and
Fischer groups [9–13] that demonstrated the importance
of SMN (and other protein components of the SMN
complex) in both the assembly of individual snRNP com-
plexes and the generation of active spliceosomes. Both
roles appear to be mediated by interaction of SMN with a
subset of the core Sm and LSm proteins. SMN interacts
directly with Sm proteins B/B′, D1 and D3, and with LSm
4, via the RG-rich domains present in the carboxy-terminal
regions of these proteins [7,8].
Ribosome production: assembly of snoRNPs
The small nucleolar (sno)RNAs are a large family of trans-
acting RNAs that function in the biogenesis of ribosomes
in the nucleolus (reviewed in [15,16]). The snoRNAs are
required for cleavage and modification of ribosomal (r)RNA.
There are two classes of snoRNAs that are distinguished
by conserved sequence features, associated proteins and
the type of modifications that they direct. New work from
the Dreyfuss laboratory [3], published recently in Current
Biology, indicates that SMN interacts with both fibrillarin
and GAR1, core protein components of the Box C/D and
Box H/ACA snoRNPs, respectively. These interactions
have also been identified, independently, in our laboratory
([5] and our unpublished data).
In vitro binding assays performed with full-length and
truncated forms of the protein showed that SMN interacts
directly with both fibrillarin and GAR1, and that the inter-
actions are mediated by the RG-rich domains at the amino
terminus (fibrillarin and GAR1) and/or carboxyl terminus
(GAR1) of the proteins ([3,5] and our unpublished data).
Also, specific point mutations identified in individuals with
spinal muscular atrophy were found to impair association
of SMN with each of the core snoRNP proteins ([3,5] and
our unpublished data). The interactions were also shown
to occur in vivo in human cells [3,5]. The snoRNPs are
ribonucleoprotein particles very much akin to snRNPs, and
the clear implication is that SMN also plays a role in the
assembly of snoRNPs.
Transcription: generation of transcription machinery
Other recent results suggest that the SMN complex may
also be responsible for the assembly of the major transcrip-
tion machinery of the cell. The Dreyfuss group [4] has
shown that the SMN complex interacts with RNA
helicase A in vivo. RNA helicase A is an ATP-dependent
DEAH-box RNA helicase that physically associates with
RNA polymerase II and has been reported to play a part in
transcription. In vitro binding studies demonstrated that,
yet again, SMN interacts directly with RNA helicase A via
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the latter protein’s carboxy-terminal RG-rich domain. Dis-
ruption of SMN function in vivo, using a dominant nega-
tive mutant form of SMN, inhibited transcription by RNA
polymerases I and III, as well as RNA polymerase II, indi-
cating that SMN may be required to generate each of the
three major transcription complexes.
SMN and coilin
Coilin is the defining molecular marker of the intranuclear
structures known as Cajal bodies. Recent work by the
Matera group [6] suggests that SMN is recruited to Cajal
bodies by a direct interaction with coilin. The RG-rich
domain of coilin was found to mediate SMN binding both
in vivo and in vitro. The interaction was disrupted by
mutation of the RG-rich domain of coilin, and a carboxy-
terminal fragment of coilin containing the RG-rich domain
was sufficient for SMN association in vivo. Furthermore,
while transient expression of wild-type coilin in embryonic
fibroblasts from a coilin knockout mouse restored the
formation of SMN-containing Cajal bodies, expression of
RG domain coilin mutants did not [6,17].
SMN binding
There is currently conflicting evidence on which part of
SMN interacts with the RG-rich regions of the various
target proteins. The work of the Dreyfuss group indicates
that the carboxy-terminal region of SMN mediates
binding to Sm and LSm proteins, RNA helicase A, fibril-
larin and GAR1 [3,4,8,14]. Other laboratories have found
that SMN’s so-called Tudor domain directly mediates
binding to Sm proteins, coilin, fibrillarin and GAR1
[5,6,9,10]. Tudor domains are conserved protein modules
that are thought to mediate protein–protein interactions
and are often found in RNA-associated proteins [2]. 
A recent NMR study has revealed that negatively charged
residues surrounding a hydrophobic pocket in the barrel-
like structure of SMN’s Tudor domain interact with the
RG-rich carboxy-terminal tails of Sm proteins [2]. The
experiments by the Dreyfuss laboratory did not directly
test the role of the Tudor domain. The ability of the
Tudor domain alone to mediate specific binding of several
partner proteins ([5,6,9] and our unpublished data), along
with the specific interactions observed by NMR [2], would
seem to indicate that the Tudor domain is the primary
SMN binding site for RG-rich proteins.
Another important aspect of SMN interaction may be the
methylation state of the target protein. In most (or all)
cases, arginines within the RG-rich domains of the target
proteins are post-translationally methylated. The Dreyfuss
laboratory has demonstrated that dimethylation markedly
enhances SMN binding to RG repeats and that, at least
in the case of Sm proteins D1 and D3, SMN displays a
clear preference for the naturally occurring symmetrically
dimethylated forms over asymmetrically dimethylated
forms [7]. 
All roads lead to the Cajal body
The Cajal body appears to be the nuclear site where SMN
facilitates assembly of various diverse cellular complexes
(Figure 1). The Cajal body is the one cellular structure
known to contain SMN, as well as the recently identified
SMN targets and other factors involved in the pre-mRNA
and pre-rRNA processing and transcription pathways. Fur-
thermore, removal of the amino-terminal 27 amino acids of
SMN produces a dominant-negative phenotype in which
enlarged Cajal bodies specifically accumulate the SMN
target proteins [3,4,18]. The missing amino acids may be
Figure 1
Assembly of cellular complexes by SMN. SMN
interacts with target proteins through their
RG-rich domains. The known target proteins
are components of spliceosomes and
snRNPs, snoRNPs, transcriptosomes and
Cajal bodies. The SMN complex is thought to
mediate assembly of the complexes, which are
required for key cellular processes including
pre-mRNA splicing, ribosome biogenesis and
transcription. It is proposed that most of these
assembly reactions take place in the Cajal
body (with the exception of the assembly of
some snRNPs in the cytoplasm). The
interaction of SMN with coilin has been
proposed to recruit SMN to Cajal bodies.
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important for SMN’s ability to assemble complexes, release
bound target proteins or transport the assembled com-
plexes from the Cajal bodies. For many years the function
of the Cajal body has been a puzzle. Gall [19] has recently
proposed that Cajal bodies serve as pre-assembly sites for
transcriptosomes. SMN appears to be the link between the
diverse constituents of the Cajal body, including spliceo-
somes and snoRNPs as well as transcriptosomes, and may
have finally revealed the Cajal body’s raison d’être.
Concluding remarks
The studies described here have provided connections
between SMN and macromolecular complexes involved in
mRNA splicing, ribosome production and transcription
(Figure 1). SMN interacts with integral components of
snoRNPs and transcription complexes, as well as snRNPs
and spliceosomes, by apparently similar mechanisms involv-
ing the common RG-rich domains. The SMN complex has
been shown to mediate the assembly of snRNPs and
spliceosomes, and is now also hypothesized to play a role
in assembly of snoRNPs and transcription machinery. The
current research suggests that spinal muscular atrophy
results from a deficiency in the assembly of some macro-
molecular complex(es) that are particularly critical to the
function of motor neurons. 
Acknowledgements
We are grateful to Utz Fischer and Claiborne V.C. Glover III for their com-
ments. The work in our laboratory is supported by the NIH, NSF and Ameri-
can Cancer Society.
References
1. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L,
Benichou B, Cruaud C, Millasseau P, Zeviani M, et al.: Identification
and characterization of a spinal muscular atrophy-determining
gene. Cell 1995, 80:155-165.
2. Selenko P, Sprangers R, Stier G, Buhler D, Fischer U, Sattler M: SMN
tudor domain structure and its interaction with the Sm proteins.
Nat Struct Biol 2001, 8:27-31.
3. Pellizzoni L, Baccon J, Charroux B, Dreyfuss G: The survival of motor
neurons (SMN) protein interacts with the snoRNP proteins
fibrillarin and GAR1. Curr Biol 2001, 11:1079-1088.
4. Pellizzoni L, Charroux B, Rappsilber J, Mann M, Dreyfuss G:
A functional interaction between the survival motor neuron
complex and RNA polymerase II. J Cell Biol 2001, 152:75-85.
5. Jones KW, Gorzynski K, Hales CM, Fischer U, Badbanchi F,
Terns RM, Terns MP: Direct interaction of the spinal muscular
atrophy disease protein SMN with the small nucleolar RNA-
associated protein fibrillarin. J Biol Chem 2001, in press.
6. Hebert D, Szymczyk PW, Shpargel KB, Matera AG: Coilin forms the
bridge between Cajal bodies and SMN, the Spinal Muscular
Atrophy protein. Genes Dev 2001, in press.
7. Friesen WJ, Massenet S, Paushkin S, Wyce A, Dreyfuss G: SMN, the
product of the spinal muscular atrophy gene, binds preferentially
to dimethylarginine-containing protein targets. Mol Cell 2001,
7:1111-1117.
8. Friesen WJ, Dreyfuss G: Specific sequences of the Sm and Sm-like
(Lsm) proteins mediate their interaction with the spinal muscular
atrophy disease gene product (SMN). J Biol Chem 2000,
275:26370-26375.
9. Buhler D, Raker V, Luhrmann R, Fischer U: Essential role for the
tudor domain of SMN in spliceosomal U snRNP assembly:
implications for spinal muscular atrophy. Hum Mol Genet 1999,
8:2351-2357.
10. Fischer U, Liu Q, Dreyfuss G: The SMN-SIP1 complex has an
essential role in spliceosomal snRNP biogenesis. Cell 1997,
90:1023-1029.
11. Liu Q, Fischer U, Wang F, Dreyfuss G: The spinal muscular atrophy
disease gene product, SMN, and its associated protein SIP1 are in
a complex with spliceosomal snRNP proteins. Cell 1997,
90:1013-1021.
12. Meister G, Buhler D, Laggerbauer B, Zobawa M, Lottspeich F,
Fischer U: Characterization of a nuclear 20S complex containing
the survival of motor neurons (SMN) protein and a specific subset
of spliceosomal Sm proteins. Hum Mol Genet 2000, 9:1977-1986.
13. Meister G, Bühler D, Pillai R, Lottspeich F, Fischer U: A multiprotein
complex mediates the ATP-dependent assembly of spliceosomal
U snRNPs. Nat Cell Biology 2001, in press.
14. Pellizzoni L, Charroux B, Dreyfuss G: SMN mutants of spinal
muscular atrophy patients are defective in binding to snRNP
proteins. Proc Natl Acad Sci USA 1999, 96:11167-11172.
15. Weinstein LB, Steitz JA: Guided tours: from precursor snoRNA to
functional snoRNP. Curr Opin Cell Biol 1999, 11:378-384.
16. Terns MP, Terns RM: Small nucleolar RNAs: versatile trans-acting
molecules of ancient evolutionary origin. Gene Exp 2001, in press.
17. Tucker KE, Berciano MT, Jacobs EY, LePage DF, Shpargel KB,
Rossire JJ, Chan EK, Lafarga M, Conlon RA, Matera AG: Residual
Cajal bodies in coilin knockout mice fail to recruit Sm snRNPs and
SMN, the spinal muscular atrophy gene product. J Cell Biol 2001,
154:293-307.
18. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G: A novel function for
SMN, the spinal muscular atrophy disease gene product, in pre-
mRNA splicing. Cell 1998, 95:615-624.
19. Gall JG: Cajal bodies: the first 100 years. Annu Rev Cell Dev Biol
2000, 16:273-300.
R864 Current Biology Vol 11 No 21
